Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; 14 of the 31 sources its claims cite were checked for support.

Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells

Open access

Abstract

BACKGROUND: ), a process that has been shown to impair their function. Here, we evaluated the characteristics and function of MSCs cultured under hypoxia and hypothesized that, when compared to normoxia, dedicated hypoxia will augment the functional characteristics of MSCs. METHODS: ) culture. In our second study, we evaluated the functional characteristics of MSC cultured under short-term 2% and 5% hypoxia. MSCs were evaluated for their metabolic activity, proliferation, viability, clonogenicity, gene expression, and secretory capacity. RESULTS: In long-term culture, common MSC surface marker expression (CD44 and CD105) dropped under hypoxia. Additionally, in long-term culture, MSCs proliferated significantly slower and provided lower yields under hypoxia. Conversely, in short-term culture, MSCs proliferated significantly faster under hypoxia. In both long-term and short-term cultures, MSC metabolic activity was significantly higher under hypoxia. Furthermore, MSCs cultured under hypoxia had upregulated expression of VEGF with concomitant downregulation of HMGB1 and the apoptotic genes BCL-2 and CASP3. Finally, in both hypoxia cultures, the pro-inflammatory cytokine, IL-8, was suppressed, while levels of the anti-inflammatories, IL-1ra and GM-CSF, were elevated in short-term hypoxia only. CONCLUSIONS: In this study, we demonstrate that hypoxia augments the therapeutic characteristics of both porcine and human MSCs. Yet, short-term 2% hypoxia offers the greatest benefit overall, exemplified by the increase in proliferation, self-renewing capacity, and modulation of key genes and the inflammatory milieu as compared to normoxia. These data are important for generating robust MSCs with augmented function for clinical applications.

Overview

CoChat Summary

## TL;DR

Short-term physiological hypoxia improved mesenchymal stem cell (MSC) function more than long-term hypoxia, with the strongest overall effects seen at 2% O2 for 48 h. Across human and porcine bone marrow MSCs, hypoxia increased proliferation and metabolic activity while shifting gene expression and secreted factors toward a more therapeutic profile.

## Key findings

  • In the first experiment (1% O2), 48 h hypoxia outperformed 10-day hypoxia overall: short-term hypoxia increased proliferation, while long-term hypoxia reduced surface marker expression and cell yield.
  • Under hypoxia, metabolic activity increased significantly in both species and both culture durations; the paper reports p < 0.0001 for long-term culture and p < 0.01 for short-term hMSCs.
  • In short-term hypoxia, 2% O2 gave the best overall balance of effects: proliferation increased in both species (p < 0.01 at 24 h for both; p < 0.05 at 48 h for hMSCs), clonogenicity increased, and VEGF was upregulated.
  • Hypoxia suppressed IL-8 in both long-term and short-term cultures; in short-term hypoxia, GM-CSF and IL-1ra were increased in pMSCs, while BCL-2 and CASP3 were downregulated in hMSCs.

## Methods

  • Human and porcine bone marrow MSCs were isolated from mononuclear cells and cultured under normoxia (~21% O2) or hypoxia (1%, 2%, or 5% O2) using a dedicated hypoxia station.
  • Two studies were performed: 1% O2 for 10 days vs 48 h, then 24 h and 48 h at 2% or 5% O2; all experiments used P2–P3 MSCs and were run in triplicate.
  • Outcomes included flow cytometry, CFU-F clonogenicity, metabolic activity, DNA-based proliferation, qRT-PCR for selected genes, and multiplex secretion assays; statistical testing used t tests and two-way ANOVA with Tukey post hoc tests.

## Limitations

  • The paper states that the findings “will be corroborated in vivo” in a preclinical ARDS model, so the work is limited to in vitro experiments and does not yet show in vivo therapeutic efficacy.
  • The text makes evident that species differences complicate generalization: several outcomes differed between human and porcine MSCs, and the authors explicitly note inter-species variation in MSC characteristics and function.
  • Not stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13287-018-1007-x

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Surface expression of MSC markers under long-term and short-term hypoxia. (a) In long-term hypoxia, CD44 levels are decreased in hMSCs, especially under hypoxia. Levels of CD105 are decreased under hypoxia, in both human and porcine MSCs. No expression of TF (CD142) was evident in hMSCs under long-term normoxia or hypoxia culture. (b) In short-term hypoxia, all surface markers are nearly 100% besides CD105, which is decreased in hMSCs. No expression of TF was evident in hMSCs under short-term normoxia or hypoxia culture
Fig. 1 Surface expression of MSC markers under long-term and short-term hypoxia. (a) In long-term hypoxia, CD44 levels are decreased in hMSCs, especially under hypoxia. Levels of CD105 are decreased under hypoxia, in both human and porcine MSCs. No expression of TF (CD142) was evident in hMSCs under long-term normoxia or hypoxia culture. (b) In short-term hypoxia, all surface markers are nearly 100% besides CD105, which is decreased in hMSCs. No expression of TF was evident in hMSCs under short-term normoxia or hypoxia cultureCC BY · PubMed Central
Fig. 2 Characteristics of MSCs under long-term and short-term hypoxia. a Compared to normoxia, the metabolic activity of MSCs is significantly increased under 1% oxygen, particularly in long-term cultures; b In short-term culture, pMSCs show significant increase in self-renewing capacity as compared to normoxia (p < 0.01); c MSCs proliferate faster and generate greater cell yields under normoxia in long-term culture, while in short-term culture, MSCs demonstrate enhanced proliferation capacity under hypoxia; d In long-term culture, viable MSCs, shown in fluorescent green, reach a confluent state faster under normoxia; bar is 500 μm; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 2 Characteristics of MSCs under long-term and short-term hypoxia. a Compared to normoxia, the metabolic activity of MSCs is significantly increased under 1% oxygen, particularly in long-term cultures; b In short-term culture, pMSCs show significant increase in self-renewing capacity as compared to normoxia (p < 0.01); c MSCs proliferate faster and generate greater cell yields under normoxia in long-term culture, while in short-term culture, MSCs demonstrate enhanced proliferation capacity under hypoxia; d In long-term culture, viable MSCs, shown in fluorescent green, reach a confluent state faster under normoxia; bar is 500 μm; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001CC BY · PubMed Central
Fig. 3 Gene expression of MSCs under long-term and short-term hypoxia. a In long-term cultures, TF, VEGF, and Ang-1 genes are upregulated in pMSCs under hypoxia. In hMSCs, VEGF (p = 0.08) and BAX (p < 0.05) were upregulated under hypoxia while HMGB1 (p = 0.08) was downregulated. (b) In short-term hypoxia culture, VEGF (p = 0.07) was upregulated while NANOG (p < 0.01) was downregulated in pMSCs. In hMSCs, VEGF (p < 0.05) was upregulated under hypoxia while the pro-apoptotic genes, BCL-2 (p < 0.01) and CASP-3 (p < 0.05), were downregulated. *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 3 Gene expression of MSCs under long-term and short-term hypoxia. a In long-term cultures, TF, VEGF, and Ang-1 genes are upregulated in pMSCs under hypoxia. In hMSCs, VEGF (p = 0.08) and BAX (p < 0.05) were upregulated under hypoxia while HMGB1 (p = 0.08) was downregulated. (b) In short-term hypoxia culture, VEGF (p = 0.07) was upregulated while NANOG (p < 0.01) was downregulated in pMSCs. In hMSCs, VEGF (p < 0.05) was upregulated under hypoxia while the pro-apoptotic genes, BCL-2 (p < 0.01) and CASP-3 (p < 0.05), were downregulated. *p < 0.05; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 4 Secretion profile of MSCs under long-term and short-term hypoxia. (a) In long-term culture, IL-8 levels were suppressed under hypoxia in both human and porcine MSCs. (b) In short-term culture, IL-8 was similarly suppressed under hypoxia in both human and porcine MSCs (p < 0.06). In pMSCs, significantly higher levels of the anti-inflammatories, GM-CSF (p < 0.05) and IL-1ra (p < 0.01) were secreted under hypoxia, as compared to normoxia
Fig. 4 Secretion profile of MSCs under long-term and short-term hypoxia. (a) In long-term culture, IL-8 levels were suppressed under hypoxia in both human and porcine MSCs. (b) In short-term culture, IL-8 was similarly suppressed under hypoxia in both human and porcine MSCs (p < 0.06). In pMSCs, significantly higher levels of the anti-inflammatories, GM-CSF (p < 0.05) and IL-1ra (p < 0.01) were secreted under hypoxia, as compared to normoxiaCC BY · PubMed Central
Fig. 5 Surface expression of MSC markers under 2% and 5% short-term hypoxia. (a) Under 2% hypoxia, all MSC positive surface markers were above 95%. (b) In contrast, under 5% hypoxia, there was a significant reduction (p < 0.0001) in CD105 expression in hMSCs at noth 24 and 48 hours. This reduction was not evident in pMSCs where surface expression was maintained above 99%
Fig. 5 Surface expression of MSC markers under 2% and 5% short-term hypoxia. (a) Under 2% hypoxia, all MSC positive surface markers were above 95%. (b) In contrast, under 5% hypoxia, there was a significant reduction (p < 0.0001) in CD105 expression in hMSCs at noth 24 and 48 hours. This reduction was not evident in pMSCs where surface expression was maintained above 99%CC BY · PubMed Central
Fig. 6 MSC characteristics under 2% and 5% short-term hypoxia. a The metabolic activity of MSCs was significantly elevated under both 2% and 5% hypoxia, when compared to normoxia; b The clonogenic capacity of hMSCs was significantly increased under hypoxia, while for pMSCs it was decreased after 48 h under 5% hypoxia; c Proliferation of MSCs was significantly increased under 2% hypoxia, whereas a significantly lower rate of proliferation was seen under 5% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 6 MSC characteristics under 2% and 5% short-term hypoxia. a The metabolic activity of MSCs was significantly elevated under both 2% and 5% hypoxia, when compared to normoxia; b The clonogenic capacity of hMSCs was significantly increased under hypoxia, while for pMSCs it was decreased after 48 h under 5% hypoxia; c Proliferation of MSCs was significantly increased under 2% hypoxia, whereas a significantly lower rate of proliferation was seen under 5% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001CC BY · PubMed Central
Fig. 7 Gene expression under 2% and 5% short-term hypoxia. (a) Under 2% short-term hypoxia, there was a significant upregulation in the angiogenic gene, VEGF, with a concomitant downregulation in the expression of HMBG1 in both human and porcine MSCs. Additionally, under hypoxia, the stem cell gene, NANOG, was downregulated in porcine, but not human MSCs, while TF and HIF antagonist were downregulated in human, but not porcine MSCs. (b) Similar to 2% hypoxia, under 5% hypoxia, the VEGF gene was significantly upregulated under hypoxia in both human and porcine MSCs, while HMGB1 and HIF antagonist were downregulated in hMSCs. As opposed to 2% hypoxia, TF was significantly upregulated in pMSCs under 5% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 7 Gene expression under 2% and 5% short-term hypoxia. (a) Under 2% short-term hypoxia, there was a significant upregulation in the angiogenic gene, VEGF, with a concomitant downregulation in the expression of HMBG1 in both human and porcine MSCs. Additionally, under hypoxia, the stem cell gene, NANOG, was downregulated in porcine, but not human MSCs, while TF and HIF antagonist were downregulated in human, but not porcine MSCs. (b) Similar to 2% hypoxia, under 5% hypoxia, the VEGF gene was significantly upregulated under hypoxia in both human and porcine MSCs, while HMGB1 and HIF antagonist were downregulated in hMSCs. As opposed to 2% hypoxia, TF was significantly upregulated in pMSCs under 5% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001CC BY · PubMed Central
Fig. 8 Secretion profile of MSCs under 2% and 5% short-term hypoxia. (a) Under 2% short-term hypoxia, IL-6 and IL-8 secreted by pMSCs were significantly suppressed while GM-CSF, IFN-γ, IL-1ra, and IL-18 were significantly increased. In hMSCs, IFN-γ and IL-18 were significantly increased under 2% hypoxia. (b) Similar to 2% hypoxia, 5% hypoxia significantly suppressed the secretion of the pro-inflammatories IL-6 and IL-8 in pMSCs. Unlike 2%, 5% hypoxia concomitantly suppressed the secretion of GM-CSF, IFN-γ, IL-1α, IL-2, IL-4, and IL-10. In hMSCs, as in pMSCs, IL-8 and GM-CSF levels were suppressed, while the secretion of IL-12 was increased under hypoxia, similar to the 2% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 8 Secretion profile of MSCs under 2% and 5% short-term hypoxia. (a) Under 2% short-term hypoxia, IL-6 and IL-8 secreted by pMSCs were significantly suppressed while GM-CSF, IFN-γ, IL-1ra, and IL-18 were significantly increased. In hMSCs, IFN-γ and IL-18 were significantly increased under 2% hypoxia. (b) Similar to 2% hypoxia, 5% hypoxia significantly suppressed the secretion of the pro-inflammatories IL-6 and IL-8 in pMSCs. Unlike 2%, 5% hypoxia concomitantly suppressed the secretion of GM-CSF, IFN-γ, IL-1α, IL-2, IL-4, and IL-10. In hMSCs, as in pMSCs, IL-8 and GM-CSF levels were suppressed, while the secretion of IL-12 was increased under hypoxia, similar to the 2% hypoxia; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 3 Not checked · 89 Own results and interpretations

65 more claims

Create a free account to see all 100 claims and to verify the 17 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 75 references

Cited by

See all 144

Metadata

Authors
Antebi, B., Rodriguez, L. A., Walker, K. P., Asher, A. M., Kamucheka, R. M., Alvarado, L., Mohammadipoor, A., & Cancio, L. C.
Affiliations
United States Army Institute of Surgical Research (US)
Corresponding author
Antebi, Ben
Venue
Stem Cell Research & Therapy
Published
2018-10-11
Volume
9
Issue
1
Pages
265-265
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2897996477
Cited by
137
References
75
Citations by year
2026: 13 · 2025: 10 · 2024: 18 · 2023: 28 · 2022: 23 · 2021: 21 · 2020: 14 · 2019: 10
FWCI
6.38
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
USAMRMC Combat Casualty Care RAD (X_018_2018)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
Keywords
mesenchymal stem cells, hypoxia, short-term hypoxia, self-renewal, vascular endothelial growth factor, HMGB1, apoptosis, inflammatory cytokines, interleukin-8, interleukin-1 receptor antagonist, GM-CSF, therapeutic function
MeSH terms
Animals, Cell Differentiation, Cell Survival, Gene Expression Regulation, Humans, Oxygen, Swine, Time Factors, Signal Transduction, Cell Hypoxia, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-8, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Vascular Endothelial Growth Factor A, Cell Proliferation, Caspase 3, Interleukin 1 Receptor Antagonist Protein, Mesenchymal Stem Cells, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. https://app.cochat.ai/papers/10.1186/s13287-018-1007-x
The paper
Antebi, B., Rodriguez, L. A., Walker, K. P., Asher, A. M., Kamucheka, R. M., Alvarado, L., Mohammadipoor, A., & Cancio, L. C. (2018). Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-018-1007-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.